Back to results
US 2026/0108593 A1Published application
Optimized epicutaneous vaccination
AssigneesDBV Technologies, Bionet-Asia, Co. Ltd.
InventorsHONG THAI PHAM, NATHALIE DONNE, PIERRE-LOUIS HERVE, LUCIE MONDOULET
Life of this patent
Estimating the term…
Abstract
The present invention relates to improved epicutaneous administration methods for vaccination of a subject. In particular, the present invention discloses the use of an antigen for epicutaneous immunization, wherein the antigen is administered by epicutaneous application with a skin patch device in combination with an epidermal skin treatment.
Claims20
1-23. (canceled)
A method for providing a vaccination against a pathogen in a subject in need thereof, which comprises:
- performing skin micro-perforation in a skin area in the subject to form one or more micropores, the skin micro-perforation not altering the basal layer of the epidermis and the one or more micropores extending from the surface of the skin through one or several epidermis layers, but without extending to the dermis, and
- then epicutaneously administering an antigen from the pathogen on said skin area of the subject by means of a skin patch, wherein:
- the skin patch is occlusive and comprises a backing suitable to create a hermetically closed condensation chamber on skin, and
- the antigen is deposited on the skin facing side of said backing, in dry form, and optionally in combination with one or more pharmaceutically acceptable excipients.
1 more element
Dependencies are inferred from the claim text.